After the Rebranding and Cost Increase, the Use of Vasopressin Continues to Increase Yearly Especially in Case of Acute Kidney Injury With Septic Shock: Is There Recent Data Justifying It?

Crit Care Med. 2023 Feb 1;51(2):e68-e69. doi: 10.1097/CCM.0000000000005725. Epub 2023 Jan 20.

Affiliations

¹ ICU Department, ULB University, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.
² ICU Department, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.
³ ULB University, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.
⁴ ED Department, Centre Hospitalier Universitaire Brugmann, Brussels, Belgium.

PMID: 36661471
DOI: 10.1097/CCM.0000000000005725

No abstract available

Publication types

Comment

MeSH terms

Acute Kidney Injury* / drug therapy
Acute Kidney Injury* / etiology
Humans
Norepinephrine
Shock, Septic* / drug therapy
Vasoconstrictor Agents / therapeutic use
Vasopressins / therapeutic use

Substances

Vasopressins
Vasoconstrictor Agents
Norepinephrine